Ibon Garitaonandia is the Chief Scientific Officer at CellProthera, a French clinical-stage biotechnology company developing stem cell- based therapies for ischemic diseases. Ibon is a seasoned executive with several years of experience advancing stem cell-based therapies in multiple indications from early discovery to clinical translation. He previously held leadership roles at Richmond Research Institute, Histocell, and International Stem Cell Corporation, completed a CIRM postdoctoral fellowship at Scripps Research, and obtained a PhD from the University of Florida.